Athersys (ATHX) Reports Q1 EPS of $0.06

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. AMD
10. BBIO

Go back to Athersys (ATHX) Reports Q1 EPS of $0.06

Athersys Reports First Quarter 2016 Results

May 5, 2016 4:10 PM EDT

CLEVELAND, May 05, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) today announced its financial results for the three months ended March 31, 2016.

Highlights of the first quarter of 2016 and recent events include:

Announced positive one-year follow-up results from the Phase 2 study of MultiStem® cell therapy to treat ischemic stroke demonstrating progressive improvements and significantly higher rate of excellent outcomes at one year for MultiStem-treated patients with greater benefits for patients receiving MultiStem treatment within 36 hours of the stroke;Established collaboration with HEALIOS K.K. (Healios) to develop MultiStem cell... More